Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2002 2
2003 4
2004 4
2005 4
2006 4
2007 5
2008 3
2009 4
2010 4
2011 6
2012 4
2013 4
2014 5
2015 5
2016 5
2017 5
2018 8
2019 1
2020 4
2021 5
2022 8
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Inhibitors of tissue transglutaminase.
Keillor JW, Apperley KY, Akbar A. Keillor JW, et al. Trends Pharmacol Sci. 2015 Jan;36(1):32-40. doi: 10.1016/j.tips.2014.10.014. Epub 2014 Dec 12. Trends Pharmacol Sci. 2015. PMID: 25500711 Review.
Transglutaminase inhibitors: a patent review.
Keillor JW, Apperley KY. Keillor JW, et al. Expert Opin Ther Pat. 2016;26(1):49-63. doi: 10.1517/13543776.2016.1115836. Epub 2015 Nov 24. Expert Opin Ther Pat. 2016. PMID: 26560530 Review.
Acyl transfer mechanisms of tissue transglutaminase.
Keillor JW, Clouthier CM, Apperley KYP, Akbar A, Mulani A. Keillor JW, et al. Bioorg Chem. 2014 Dec;57:186-197. doi: 10.1016/j.bioorg.2014.06.003. Epub 2014 Jun 25. Bioorg Chem. 2014. PMID: 25035302 Review.
Irreversible inhibitors of tissue transglutaminase.
Keillor JW, Chabot N, Roy I, Mulani A, Leogane O, Pardin C. Keillor JW, et al. Adv Enzymol Relat Areas Mol Biol. 2011;78:415-47. doi: 10.1002/9781118105771.ch10. Adv Enzymol Relat Areas Mol Biol. 2011. PMID: 22220480 Review. No abstract available.
Tissue transglutaminase inhibition.
Keillor JW. Keillor JW. Chem Biol. 2005 Apr;12(4):410-2. doi: 10.1016/j.chembiol.2005.04.001. Chem Biol. 2005. PMID: 15850975
Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid.
Qin XY, Furutani Y, Yonezawa K, Shimizu N, Kato-Murayama M, Shirouzu M, Xu Y, Yamano Y, Wada A, Gailhouste L, Shrestha R, Takahashi M, Keillor JW, Su T, Yu W, Fujii S, Kagechika H, Dohmae N, Shirakami Y, Shimizu M, Masaki T, Matsuura T, Suzuki H, Kojima S. Qin XY, et al. Among authors: keillor jw. Cell Death Dis. 2023 Jun 13;14(6):358. doi: 10.1038/s41419-023-05847-4. Cell Death Dis. 2023. PMID: 37308486 Free PMC article.
Novel irreversible peptidic inhibitors of transglutaminase 2.
Cundy NJ, Arciszewski J, Gates EWJ, Acton SL, Passley KD, Awoonor-Williams E, Boyd EK, Xu N, Pierson É, Fernandez-Ansieta C, Albert MR, McNeil NMR, Adhikary G, Eckert RL, Keillor JW. Cundy NJ, et al. Among authors: keillor jw. RSC Med Chem. 2022 Dec 28;14(2):378-385. doi: 10.1039/d2md00417h. eCollection 2023 Feb 22. RSC Med Chem. 2022. PMID: 36846375 Free PMC article.
91 results